How big is the Gastric Cancer Therapy Market?

The Gastric Cancer Therapy Market size is expected to reach USD 5.32 billion in 2024 and grow at a CAGR of 12.63% to reach USD 9.64 billion by 2029. Read More

What is the current Gastric Cancer Therapy Market size?

In 2024, the Gastric Cancer Therapy Market size is expected to reach USD 5.32 billion. Read More

Who are the key players in Gastric Cancer Therapy Market?

Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche Ltd, Celltrion Inc. and Merck & Co are the major companies operating in the Gastric Cancer Therapy Market. Read More

Which is the fastest growing region in Gastric Cancer Therapy Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Gastric Cancer Therapy Market?

In 2024, the North America accounts for the largest market share in Gastric Cancer Therapy Market. Read More

What years does this Gastric Cancer Therapy Market cover, and what was the market size in 2023?

In 2023, the Gastric Cancer Therapy Market size was estimated at USD 4.72 billion. The report covers the Gastric Cancer Therapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gastric Cancer Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Gastric Cancer Therapy Market Share

Statistics for the 2023 & 2024 Gastric Cancer Therapy market share, created by Mordor Intelligence™ Industry Reports. Gastric Cancer Therapy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Gastric Cancer Therapy Industry

The gastric cancer therapy market is moderately competitive and consists of a few major players. In terms of shares, a few of the major players are currently dominating the market. Some of the major players in the market are F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, Pfizer, Merck & Co. Inc., and Celltrion Inc., among others.